Altamira Therapeutics Ltd.: net_income
| Value | {"unit": "CHF", "value": -6754579, "concept": "us-gaap:NetIncomeLoss"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1958021a-9a03-45f0-9ea6-4298ebdeb37b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-046965Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001601936/net-income/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1958021a-9a03-45f0-9ea6-4298ebdeb37b
History
- no predecessors — first report